Vargas V - Search Results

1

[Seroprevalence of hepatitis A antibodies in patients with chronic hepatitis].

Bañares R, Bory F, Costa J, Dal-Ré R, González A, Navasa M, Planas R, Sansó A, Vargas V. Bañares R, et al. Among authors: vargas v. Gastroenterol Hepatol. 1996 Mar;19(3):183. Gastroenterol Hepatol. 1996. PMID: 8991665 Spanish. No abstract available.

2

Hepatitis C virus antibodies among risk groups in Spain.

Esteban JI, Esteban R, Viladomiu L, López-Talavera JC, González A, Hernández JM, Roget M, Vargas V, Genescà J, Buti M, et al. Esteban JI, et al. Among authors: vargas v. Lancet. 1989 Aug 5;2(8658):294-7. doi: 10.1016/s0140-6736(89)90485-6. Lancet. 1989. PMID: 2569102

3

Evaluation of anti-HCV positive blood donors identified during routine screening.

Esteban JI, Lopez-Talavera JC, Genescà J, Gonzalez A, Vargas V, Buti M, Guardia J, Esteban R. Esteban JI, et al. Among authors: vargas v. Arch Virol Suppl. 1992;4:244-6. doi: 10.1007/978-3-7091-5633-9_53. Arch Virol Suppl. 1992. PMID: 1450694

4

Long interval between HCV infection and development of hepatocellular carcinoma.

Castells L, Vargas V, Gonzalez A, Esteban J, Esteban R, Guardia J. Castells L, et al. Among authors: vargas v. Liver. 1995 Jun;15(3):159-63. doi: 10.1111/j.1600-0676.1995.tb00664.x. Liver. 1995. PMID: 7545775

5

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.

Navasa M, Follo A, Llovet JM, Clemente G, Vargas V, Rimola A, Marco F, Guarner C, Forné M, Planas R, Bañares R, Castells L, Jimenez De Anta MT, Arroyo V, Rodés J. Navasa M, et al. Among authors: vargas v. Gastroenterology. 1996 Oct;111(4):1011-7. doi: 10.1016/s0016-5085(96)70069-0. Gastroenterology. 1996. PMID: 8831596 Clinical Trial.

6

Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence.

Bauer TM, Follo A, Navasa M, Vila J, Planas R, Clemente G, Vargas V, Bory F, Vaquer P, Rodés J. Bauer TM, et al. Among authors: vargas v. Dig Dis Sci. 2002 Jun;47(6):1356-61. doi: 10.1023/a:1015386901343. Dig Dis Sci. 2002. PMID: 12064813 Clinical Trial.

7

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Ginès P, Rodés J. Sort P, et al. Among authors: vargas v. N Engl J Med. 1999 Aug 5;341(6):403-9. doi: 10.1056/NEJM199908053410603. N Engl J Med. 1999. PMID: 10432325 Free article. Clinical Trial.

8

[Malakoplakia of the colon with intestinal hemorrhage].

González A, Vargas V, Salas A. González A, et al. Among authors: vargas v. Med Clin (Barc). 1987 Sep 12;89(7):304-5. Med Clin (Barc). 1987. PMID: 3500378 Spanish. No abstract available.

9

[Long term follow-up of non-symptomatic HBsAg carriers].

González A, Vargas V, Hernández-Sánchez JM, Cortina M, Pelegrí D, López-Talavera JC, Genescá J, Jardí R, Esteban R, Guardia J. González A, et al. Among authors: vargas v. An Med Interna. 1991 Jun;8(6):269-72. An Med Interna. 1991. PMID: 1888839 Spanish.

10

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.

Fernández J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, Vila C, Pardo A, Quintero E, Vargas V, Such J, Ginès P, Arroyo V. Fernández J, et al. Among authors: vargas v. Gastroenterology. 2007 Sep;133(3):818-24. doi: 10.1053/j.gastro.2007.06.065. Epub 2007 Jul 3. Gastroenterology. 2007. PMID: 17854593 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

432 results

Search Page